Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for bovine health
US-10517316-B2 · Dec 31, 2019 · US
Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals
US11040045B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11040045-B2 |
| Application number | US-202015929310-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 24, 2020 |
| Priority date | Jan 15, 2015 |
| Publication date | Jun 22, 2021 |
| Grant date | Jun 22, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention relates to the use of the combination of 25-hydroxyvitamin D3 (“25-OH D3”) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of ameliorating weight gain in a hyperphagic person comprising administering an effective amount of a combination comprising: 25-hydroxyvitamin D3, Vitamin C, Vitamin E, and one or more carotenoids selected from the group consisting of: astaxanthin, cryptoxanthin, beta-carotene, lutein, zeaxanthin and canthaxanthin, wherein the combination does not include lycopene.
Assignees
Inventors
Classifications
Compositions other than spreads · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Copper; Compounds thereof · CPC title
Zinc; Compounds thereof · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11040045B2 cover?
- This invention relates to the use of the combination of 25-hydroxyvitamin D3 (“25-OH D3”) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuti…
- Who is the assignee on this patent?
- Dsm Ip Assets Bv
- What technology area does this patent fall under?
- Primary CPC classification A61K45/06. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).